Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Vaping 1 Tobacco Use Disorder 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Endometrial Neoplasms 1 Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 23 Radiosurgery 21 Temozolomide 14 Bevacizumab 12 pembrolizumab 10 Specimen Handling 9 Nivolumab 8 Radiotherapy 7 Ipilimumab 7 Magnetic Resonance Imaging 6 Cyclophosphamide 5 Capecitabine 5 Blood Specimen Collection 5 encorafenib 4 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Memantine 4 Carboplatin 4 fludarabine 3 fluciclovine F-18 3 binimetinib 3 abemaciclib 3 Watchful Waiting 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 sacituzumab govitecan 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × BID protein, human × Clear all

NCT06128148 2025-07-14

JYP0322

Guangzhou JOYO Pharma Co., Ltd

Phase 1 Recruiting

Brain Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡